NCT02666274

Brief Summary

There are many bacteria that naturally live in our gut and are essential for good health. These bacteria have a variety of helpful functions, such as aiding digestion, synthesizing vitamins, repressing the growth of harmful bacteria and defending against some diseases. The desirable bacteria that live in the gut are collectively known as 'gut flora', or more appropriately, as 'gut microbiota'. The less desirable resistant bacteria, however, can also be carried in a person's gut for prolonged periods of time and be found in the stools without causing illness. Persons that carry the resistant bacteria in the gut are known as "carriers" and they require no treatment. Knowing that a person carries resistant bacteria is helpful, because it will inform the choice of antibiotic if the person were to become unwell or had an intervention such as surgery in the future. There is some evidence that resistant bacteria found in the stools can sometimes be passed from one person to another and eventually make someone ill if they infect (invade) their body. The investigators do not know how often this may happen, or how much carrying resistant bacteria in the stools may facilitate the spread of resistant bacteria in the population. It is important to address these questions and study ways to stop the resistant bacteria from spreading to safeguard the efficacy of antibiotics.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 18, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 28, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

November 28, 2016

Status Verified

November 1, 2016

Enrollment Period

1.1 years

First QC Date

January 18, 2016

Last Update Submit

November 24, 2016

Conditions

Keywords

carbapenem resistancebacterial carriagemulti-drug resistant gram negative bacteria

Outcome Measures

Primary Outcomes (2)

  • Transmission of resistant gram negative bacteria from index participants and network participants

    To measure household transmission between index participants and household members of resistant bacteria through collection of stool samples.

    6 months

  • Length of Gut Carriage of resistant gram negative bacteria in index participants

    Measure how long resistant gram negative bacteria persist in the stool by measuring carriage of bacteria in longitudinal stool samples

    6 months

Study Arms (1)

RK Group

participants colonised with Klebsiella spp. resistant to either 3GC or carbapenems (RK cohort of index carriers of Resistant Klebsiella)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any adult hospitalized patient at Guy's and St Thomas' Foundation Trust who carries resistant gram negative bacteria on a screening or clinical sample

You may qualify if:

  • Study A ('Mapping'): Retrospective data collection from the hospital laboratory information system on patients diagnosed with infection and/or colonisation by relevant gram negative bacteria and antibiotic resistance profile.
  • Study B ('Tracking'):

You may not qualify if:

  • Study B ('Tracking'):

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guy's and St Thomas' NHS Foundation Trust

London, London, SE1 7EH, United Kingdom

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

stool samples

MeSH Terms

Conditions

Gram-Negative Bacterial Infections

Condition Hierarchy (Ancestors)

Bacterial InfectionsBacterial Infections and MycosesInfections

Study Officials

  • Jonathan Edgeworth, MBBS

    Guy's and St Thomas NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Olga Tosas, phD DVM

CONTACT

Jonathan Edgeworth, MBBS

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2016

First Posted

January 28, 2016

Study Start

December 1, 2015

Primary Completion

January 1, 2017

Study Completion

June 1, 2017

Last Updated

November 28, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share

Locations